Carolina González
Postdoctoral researcher
Carolina González
Web of Science ResearcherID: https://www.webofscience.com/wos/author/record/136266
Bio: Carolina González Riaño obtained her PhD in Pharmacy at the Universidad CEU San Pablo, Madrid (Spain) under the supervision of Prof. Coral Barbas and Prof. Antonia Garcia in 2018. Currently, she is a postdoctoral researcher at the Centre for Metabolomics and Bioanalysis (CEMBIO), Madrid (Spain). Her main field of interest involves targeted and untargeted metabolomics and lipidomics studies based on a multiplatform analytical approach (LC-MS, GC-MS, and CE-MS) to unveil the pathophysiological mechanisms behind the development of different neurodegenerative diseases. Her current research activity is also centered on applying a multiplatform untargeted metabolomics-based strategy to investigate tuberculosis.
Web of Science ResearcherID: K-2784-2015
ORCID: 0000-0001-7026-8684
Publications by Carolina González:
LiLA: lipid lung-based ATLAS built through a comprehensive workflow designed for an accurate lipid annotation
Posted on: 05 Ene 2024
Capillary electrophoresis mass spectrometry-based untargeted metabolomics to approach disease diagnosis
Posted on: 02 Abr 2023
Birth Weight and Early Postnatal Outcomes: Association with the Cord Blood Lipidome
Posted on: 12 Sep 2022
Sphingomyelin Depletion Inhibits CXCR4 Dynamics and CXCL12-Mediated Directed Cell Migration in Human T Cells
Posted on: 12 Jul 2022
Exploiting the formation of adducts in mobile phases with ammonium fluoride for the enhancement of annotation in liquid chromatography-high resolution mass spectrometry based lipidomics
Posted on: 05 Nov 2021
Analytical approaches for studying oxygenated lipids in the search of potential biomarkers by LC-MS
Posted on: 01 Oct 2021
Low and high resolution gas chromatography-mass spectrometry for untargeted metabolomics: A tutorial
Posted on: 09 Sep 2021
In vitro generation of oxidized standards for lipidomics. Application to major membrane lipid components
Posted on: 16 Ago 2021
Searching for prognostic biomarkers of Parkinson’s Disease development in the Spanish EPIC cohort through a multiplatform metabolomics approach
Posted on: 03 Mar 2021
Protocol 20: Untargeted Metabolomics Determination of Postmortem Changes in Brain Tissue Samples by UHPLC-ESI-QTOF-MS and GC-EI-Q-MS
Posted on: 01 Nov 2020
Protocol 16: GC-MS Nontargeted Metabolomics of Neural Tissue
Posted on: 01 Nov 2020
Absence of R‐Ras1 and R‐Ras2 causes mitochondrial alterations that trigger axonal degeneration in a hypomyelinating disease model
Posted on: 03 Oct 2020
Metabolic changes during respiratory syncytial virus infection of epithelial cells
Posted on: 26 Mar 2020
Recent Developments along the Analytical Process for Metabolomics Workflows
Posted on: 18 Oct 2019
Quantitative metabolic profiling of urinary eicosanoids for clinical phenotyping
Posted on: 06 Mar 2019
Metabolomic Study of Hibernating Syrian Hamster Brains: In Search of Neuroprotective Agents
Posted on: 09 Ene 2019
Target and untargeted GC–MS based metabolomic study of mouse optic nerve and its potential in the study of neurological visual diseases
Posted on: 10 May 2018
Multiplatform plasma fingerprinting in cancer cachexia: a pilot observational and translational study
Posted on: 20 Feb 2018
Metabolomics and neuroanatomical evaluation of post-mortem changes in the hippocampus
Posted on: 11 Mar 2017